Adjuvant Chemotherapy for Node-Positive Breast Cancer Patients: Which is the Reference Today?
- 15 March 2003
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (6) , 1190-1191
- https://doi.org/10.1200/jco.2003.99.223
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- Benefit of a High-Dose Epirubicin Regimen in Adjuvant Chemotherapy for Node-Positive Breast Cancer Patients With Poor Prognostic Factors: 5-Year Follow-Up Results of French Adjuvant Study Group 05 Randomized TrialJournal of Clinical Oncology, 2001
- A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group.Journal of Clinical Oncology, 1988